S Rolim Denise, Galas Filomena R B, Faria Lucilia S, Amorim Erica F, Regenga Marisa M, Troster Eduardo J
Rehabilitation Service, Hospital Sírio Libanês (HSL), Rua Do Ângulo, 412, Morumbi, São Paulo, SP, 05713-410, Brazil.
Pediatrics Department, Medical College, Universidade de São Paulo, São Paulo, SP, Brazil.
Pediatr Cardiol. 2020 Apr;41(4):729-735. doi: 10.1007/s00246-020-02290-6. Epub 2020 Feb 5.
The purpose of this study was to determine the rate of failure of noninvasive ventilation (NIV) after cardiac surgery in pediatric patients with respiratory failure after extubation and to identify predictive success factors. This was a prospective cohort study of pediatric patients diagnosed with congenital heart disease who underwent heart surgery and used NIV. Data were collected from 170 patients with a median age of 2 months. No patient presented cardiorespiratory arrest nor any other complication during the use of NIV. The success rate for the use of NIV was 61.8%. Subjects were divided for analysis into successful and failed NIV groups. Statistical analysis used Chi-square, Mann-Whitney, and Student's t tests, which were performed after univariate and multivariate logistic regression for p < 0.05. In the multivariate analysis, only the minimal pressure gradient (OR 1.45 with p = 0.007), maximum oxygen saturation (OR 0.88 with p = 0.011), and maximum fraction of inspired oxygen (FiO) (OR 1.16 with p < 0.001) influenced NIV failure. The following variables did not present a statistical difference: extracorporeal circulation time (p = 0.669), pulmonary hypertension (p = 0.254), genetic syndrome (p = 0.342), RACHS-1 score (p = 0.097), age (p = 0.098), invasive mechanical ventilation duration (p = 0.186), and NIV duration (p = 0.804). In conclusion, NIV can be successfully used in children who, after cardiac surgery, develop respiratory failure in the 48 h following extubation. Although the use of higher pressure gradients and higher FiO are associated with a greater failure rate for NIV use, it was found to be generally safe.
本研究的目的是确定小儿心脏手术后拔管后发生呼吸衰竭时无创通气(NIV)的失败率,并确定预测成功的因素。这是一项对诊断为先天性心脏病并接受心脏手术且使用NIV的小儿患者进行的前瞻性队列研究。收集了170例中位年龄为2个月的患者的数据。在使用NIV期间,没有患者出现心肺骤停或任何其他并发症。NIV的使用率为61.8%。将受试者分为NIV成功组和失败组进行分析。统计分析采用卡方检验、曼-惠特尼检验和学生t检验,在单因素和多因素逻辑回归后进行,p<0.05。在多因素分析中,只有最小压力梯度(OR 1.45,p = 0.007)、最大氧饱和度(OR 0.88,p = 0.011)和最大吸入氧分数(FiO)(OR 1.16,p<0.001)影响NIV失败。以下变量无统计学差异:体外循环时间(p = 0.669)、肺动脉高压(p = 0.254)、遗传综合征(p = 0.342)、RACHS-1评分(p = 0.097)、年龄(p = 0.098)、有创机械通气时间(p = 0.186)和NIV时间(p = 0.804)。总之,NIV可成功用于心脏手术后拔管后48小时内发生呼吸衰竭的儿童。虽然使用较高的压力梯度和较高的FiO与NIV使用的较高失败率相关,但发现其总体上是安全的。